ENTITY

Bio Techne Corp (TECH US)

27
Analysis
Health Care • United States
Bio-Techne Corp develops, manufactures and sells biotechnology products and clinical diagnostic controls. The Company specializes in proteins, cytokines, growth factors, immunoassays and small molecules.
more
bullish•Bio Techne Corp
•25 May 2023 03:03

Bio-Techne Corporation: Collaboration With Lunaphore & Other Drivers

Bio-Techne had a weak quarter, with revenues below market expectations. Its revenue growth was not up to the mark despite the key drivers being...

Logo
372 Views
Share
bullish•Bio Techne Corp
•15 Feb 2023 01:22

Bio-Techne Corporation: Expansion RNAscope & Other Drivers

Bio-Techne delivered a disappointing result in the last quarter while failing to meet Wall Street expectations in terms of revenues as well as...

Logo
325 Views
Share
bullish•Bio Techne Corp
•18 Nov 2022 00:36

Bio-Techne Corp: Advanced Cell Diagnostics RNAscope System Developments & Other Drivers

Bio-Techne has been going through a tough 2022 and witnessed a slow summer especially in the European markets as well as Covid-related shutdowns...

Logo
386 Views
Share
bullish•Bio Techne Corp
•14 Jul 2022 01:05

Bio-Techne Corporation: Initiation of Coverage – The Namocell Acquisition & Other Developments

This is our first report on Bio-Techne Corporation. The company delivered a strong financial performance in the past quarter, surpassing Wall...

Logo
144 Views
Share
bullish•Qiagen N.V.
•21 Jul 2020 20:02

Qiagen/Thermo Fisher: Qiagen Gets a Bump – Is It Enough to Satisfy Shareholders?

QIAGEN NV (QIA GY) shares have gone from strength to strength with the stock trading above terms and then receiving a bump bid late last week....

Logo
596 Views
Share
x